Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CM-101 by Chemomab Therapeutics for Liver Fibrosis: Likelihood of Approval
CM-101 is under clinical development by Chemomab Therapeutics and currently in Phase II for Liver Fibrosis. According to GlobalData, Phase...
CM-101 by Chemomab Therapeutics for Primary Sclerosing Cholangitis: Likelihood of Approval
CM-101 is under clinical development by Chemomab Therapeutics and currently in Phase II for Primary Sclerosing Cholangitis. According to GlobalData,...
CM-101 by Chemomab Therapeutics for Systemic Sclerosis (Scleroderma): Likelihood of Approval
CM-101 is under clinical development by Chemomab Therapeutics and currently in Phase I for Systemic Sclerosis (Scleroderma). According to GlobalData,...